metricas
covid
Vacunas Lo más citado
Información de la revista

Lo más citado

Datos disponibles en articúlos publicados a partir del año 2014

3
COVID-19 story: Entry and immune response
Ali Mohammed Ashraf, Marwan Y. Al-Maqtoofi, Ahmed A. Burghal
Vacunas. 2025;26:100380
3
3
Modeling the booster vaccine effect on new COVID-19 variant management employs the Atangana-Baleanu-Caputo fractional derivative operator together with the Laplace-Adomian decomposition method
M.O. Olayiwola, K.R. Tijani, M.O. Ogunniran, A.O. Yunus, E.A. Oluwafemi, M.O. Abanikanda, A.I. Alaje, J.A. Adedeji
Vacunas. 2025;26:500458
3
3
Bibliometric analysis of circular RNA cancer vaccines and their emerging impact
Uddalak Das, Soupayan Banerjee, Meghna Sarkar
Vacunas. 2025;26:500391
3
2
A narrative review on the white spot syndrome virus and the perspective of vaccine development
Susithra Priyadarshni Mugunthan, Nivetha Loganathan, Balamurugan Shanmugaraj, Harish Mani Chandra
Vacunas. 2025;26:100382
2
2
An overview of anticancer roles of nanoparticles synthesized by microbes
A. Hosseingholian, P. Jafari, A. Abedini, H. Jooya, J.D. Gross, M. Beyranvand, A. Samadi, S. Khoshnood
Vacunas. 2025;26:500388
2
1
Development of a novel multi-epitope vaccine candidate for Marburg virus applying advanced immunoinformatics strategies: A computational analysis
Md. Nafij Mashrur, M. Nazmul Hoque, Soharth Hasnat, Sakhawat Hossen Saikat, Md. Mehedi Hasan, Faria Khan Hridy, Nurul Amin Rani, Fardous Mohammad Safiul Azam
Vacunas. 2025;26:500461
1
1
Would senior citizens get vaccinated against RSV? Exploratory analysis using a novel survey instrument
Mohammad Abu-Ghosh, Dareen Saleh, Joud Al-Haddad, Leen Sabbah, Raghad Alnusairat, Muna Barakat, Malik Sallam
Vacunas. 2025;26:100384
1
Acceso a texto completo
Artículo abierto